N@N

Market Maker Surveillance Report. AGEN, BONT, MAG, IBIO, WZE, IMRS, Winning Stocks With Lowest Price Friction For Wednesday, M

March 7, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 3634 companies with "abnormal" market making, 3963 companies with positive Friction Factors and 1911 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Wednesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. AGENUS INC (NASDAQ:AGEN), BON-TON STORES INC/THE (NASDAQ:BONT), MAGNETEK INC (NYSE:MAG), IBIO INC (AMEX:IBIO), WIZZARD SOFTWARE CORP (AMEX:WZE), IMRIS INC (NASDAQ:IMRS). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  AGEN    $0.730    19.41%    553,130      54.91%    453,906      45.06%    99,224       1,359   
  BONT    $1.050    20.00%    1,439,735    54.82%    1,162,043    44.24%    277,692      2,645   
  MAG     $3.460    24.13%    117,229      70.14%    42,586       25.48%    74,643       216     
  IBIO    $0.320    35.96%    160,654      28.26%    143,056      25.16%    17,598       550     
  WZE     $0.330    15.94%    58,594       43.81%    41,221       30.82%    17,373       526     
  IMRS    $0.440    16.48%    155,340      70.98%    63,219       28.89%    92,121       2,094   

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows AGEN with a dollar gain Wednesday of $0.73000 and a Friction Factor of 1,359 shares. That means that it only took 1,359 more shares of buying than selling to move AGEN higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

AGENUS INC (NASDAQ:AGEN) - Agenus Inc., a biotechnology company, develops and commercializes immunotherapies for cancer and infectious diseases. It markets Oncophage vaccine for the treatment of adjuvant renal cell carcinoma (kidney cancer). The company also has various product candidates under development, which include QS-21 Stimulon adjuvant, which is in Phase III clinical trials for the treatment of non-small cell lung cancer, melanoma, malaria, and singles, as well as in Phase II clinical trials for the treatment of Alzheimers disease. In addition, the companys product candidates under development comprise Prophage, which is in Phase II clinical trials for the treatment of glioma (brain cancer) and pediatric neurological tumors; and HerpV, which is in Phase I clinical trials for the treatment of genital herpes. Further, it has various other undisclosed vaccines in Phase I and II studies. The company was formerly known as Antigenics Inc. and changed its name in January, 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.

BON-TON STORES INC/THE (NASDAQ:BONT) - The Bon-Ton Stores, Inc., through its subsidiaries, operates department stores in the mid-size and metropolitan markets of the United States. Its stores offer brand-name fashion apparel and accessories for women, men, and children, as well as provide cosmetics, home furnishings, and footwear. As of January 29, 2011, the company operated 275 stores under various nameplates, including the Bon-Ton, Bergners, Boston Store, Carson Pirie Scott, Elder-Beerman, Herbergers, and Younkers in 23 northeastern, midwestern, and upper Great Plains states; and under the Parisian nameplate in Detroit, Michigan. The Bon-Ton Stores, Inc. was founded in 1898 and is headquartered in York, Pennsylvania.

MAGNETEK INC (NYSE:MAG) - Magnetek, Inc. provides digital power control systems North America. Its systems control motion and power primarily in material handling, elevator, and energy delivery applications. The company offers power control and delivery systems and solutions for overhead material handling applications used in industries, such as aerospace, automotive, steel, aluminum, paper, logging, mining, ship loading, nuclear power plants, locomotive yards, and heavy movable structures. Its material handling products, including drive systems, radio remote controls, braking, collision-avoidance, and electrification subsystems. The company also designs, builds, sells, and supports elevator application integrated subsystems and drives, which comprise DC high performance elevator drives and AC drives for low and high performance traction elevators to control motion primarily in high-rise and high speed elevator applications. In addition, Magnetek offers energy delivery products consisting of power inverters for fuel cells, solar panels, and wind turbines, which deliver AC power from these energy sources to the utility power grid. Its products are sold directly or through manufacturers representatives to original equipment manufacturers, system integrators, and value-added resellers; distributors for resale; and end-users. The company was founded in 1984 and is headquartered in Menomonee Falls, Wisconsin.

IBIO INC (AMEX:IBIO) - iBio, Inc., a biopharmaceutical company, focuses on the development of vaccines and therapeutic proteins based upon its proprietary plant-based iBioLaunch Platform Technology. The company principally focuses on advancing a H1N1 influenza vaccine candidate to clinical trials and to establish business arrangements for use of the technology by licensees for the development and production of other products for the prevention and treatment of various infectious diseases, including influenza, anthrax, and human papilloma virus. iBio holds a research and development agreement with the Fraunhofer USA Center for Molecular Biotechnology and has exclusive rights to the proprietary platform developed under the agreement for human health applications for developing vaccines and therapeutic products for a broad range of medical indications and for veterinary applications of plant-based influenza vaccines. The company was formerly known as iBioPharma, Inc. and changed its name to iBio, Inc. in August 2009. iBio is headquartered in Newark, Delaware.

WIZZARD SOFTWARE CORP (AMEX:WZE) - Wizzard Software Corporation provides software products and services for the speech recognition and text-to-speech technology. It operates in three segments Software, Healthcare, and Media Services. The Software segment engages in the development, sale, and service of custom and packaged computer software products; and sells and supports text-to-speech engines and speech recognition engines to software developers and businesses. The Media Services segment offers podcast hosting, distribution, audience analysis, content management tools, advertising, and app sales for podcast producers. This segment provides a Web based podcast distribution platform to broadcast audio or video show for podcast producers. As of December 31, 2009, it distributed approximately 1.4 billion podcast episodes. The Healthcare segment provides home healthcare services, including a range of visiting nurse services to the elderly, wounded, and sick people; and healthcare staffing services in Wyoming and Montana. The company was founded in 1995 and is based in Pittsburgh, Pennsylvania.

IMRIS INC (NASDAQ:IMRS) - IMRIS Inc. provides integrated image guided therapy solutions that deliver information to clinicians during surgical or interventional procedures. These solutions feature integrated surgical and interventional suites that incorporate magnetic resonance (MR) imaging, fluoroscopy, and computed tomography to deliver on demand imaging during procedures. The companys flagship product, IMRISneuro, an integrated MR imaging system, combines a high-field MR scanner with a computer-controlled transport system and MR-compatible surgical table to allow high resolution imaging of patient anatomy during various surgical procedures, including cranial, spinal, and general surgery. The IMRISneuro system includes an integrated data management system, which allows surgical teams to collect, display, and share patient information in real time within the operating room or with others outside the operating room, including students or consulting surgeons. It also provides IMRIScardio suite comprising a wide-bore 1.5 Tesla MR scanner and a single-plane angiography system, which offer images and information for visualizing the cardiovascular system before, during, and after an intervention; and IMRISNV suite consisting of a wide-bore 3 Tesla MR scanner and a bi-plane angiography system that permits the patient to transition between MRI and intervention without transporting the patient between modalities and provides interventional clinicians with imaging for the assessment and post procedure evaluation of neurovascular conditions, including stroke. The companys systems serve the neurosurgical, cardiovascular, and neurovascular markets worldwide. IMRIS Inc. has an agreement with Varian Medical Systems Inc. to co-develop MR-guided radiation therapy systems for use in treating various cancers. The company is headquartered in Winnipeg, Canada.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net